News | July 20, 2022
Healthcare Startup Shri Chyawan Ayurved raises USD 200k in SEED round
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
An algorithm based testing for Fatty Liver Disease
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The array available for a subscription includes popular products to make menstrual hygiene a regular practice and extend further affordability to its users
Bringing next-gen cannabinoid therapeutics to cancer patients
Amarex Clinical Research guides its client to phase II of FDA trials
Dupixent is the first and only biologic medicine approved to treat moderate-to-severe atopic dermatitis from infancy to adulthood
The drug will be manufactured at the group’s topical facility at Ahmedabad
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S., if approved
Subscribe To Our Newsletter & Stay Updated
